Cover Image
市場調查報告書

中國的Sertraline市場分析

Investigation Report on China Sertraline Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 334089
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Sertraline市場分析 Investigation Report on China Sertraline Market, 2010-2019
出版日期: 2015年07月02日 內容資訊: 英文 35 Pages
簡介

Sertraline的年度銷售額從2005年的2,000萬人民幣,到2014年達成1億4,800萬人民幣,年複合成長率達到了23.50%的成長。

本報告提供中國的Sertraline市場相關調查分析,提供您市場規模,競爭情形,各企業的零售價格,市場預測相關的系統性資訊。

第1章 Sertraline的相關概念

  • 適應
  • 全球市場銷售情形

第2章 中國的Sertraline的市場簡介

  • 中國的Sertraline的專利·核準情況
  • 主要製造商
  • 市場規模

第3章 中國的Sertraline銷售分析

  • 銷售額
  • 銷售額數量

第4章 中國的Sertraline主要廠商的市場佔有率分析

  • 市場佔有率:銷售額別
  • 市場佔有率:銷售量別

第5章 中國的Sertraline的各劑型分析

  • 市場佔有率 (各劑型) :銷售額別
  • 市場佔有率 (各劑型) :銷售量別

第6章 中國的Sertraline的醫院用標準價格

第7章 中國市場的Sertraline的主要製造商

  • Zhejiang Jingxin Pharmaceutical Co., Ltd
  • Tianjin Huajin Pharmaceutical Factory
  • Guangdong P.D. Pharmaceutical Co., Ltd
  • Zhejiang Huahai Pharmaceutical Co., Ltd
  • Pfizer, Inc.

第8章 中國的Sertraline的市場預測

  • 市場規模的預測
  • 競爭情形的預測

圖表

目錄
Product Code: 1507250

According to WHO, depression, an affective mental disorder, is quite common with an incidence of 3-5%. Currently, the number of depression patients has exceeded 90 million in China and still keeps increasing. It is expected that by 2020, depression will become the second biggest threat to human health.

Developed by Pfizer, Inc. in the early 1990s, sertraline (sertraline dydrochloride) has entered many countries like the US, European countries and Japan to treat dysthymi and has brought in an annual sales value of over 1 billion all over the world. As the newest product of selective serotonin reuptake inhibitor (SSRI), sertraline can help improve organism ability, reduce symptoms of depression like distress and alleviate persistent fatigue and anxiety. As one of the three SSRI drugs with certain efficacy (the other two being fluoxetine and paroxetine), sertraline has been widely used for the treatment of depressive disorder and obsessive-compulsive disorder.

According to CRI's market survey, sertraline keeps growing with annual sales value rising from CNY 20 million in 2005 to CNY 148 million in 2014 and CAGR during this period reaching 23.50% after it entered China in 1996. Pfizer, Inc., Zhejiang Jingxin Pharmaceutical Co., Ltd, Tianjin Huajin Pharmaceutical Factory, Guangdong P.D. Pharmaceutical Co., Ltd and Chengdu Leer Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Pfizer, Inc. had the largest market share of about 83% for sales value in 2014.

With the increased mental pressure brought about by economic development and lifestyle change, the number of depression patients keeps growing too. Therefore, the market size of sertraline is expected to expand in the next few years in China.

Readers can get at least the following information from this report:

  • market size of sertraline in China
  • competitive landscape of sertraline in Chinese market
  • price of sertraline made by different enterprises in China
  • market outlook of sertraline in China

The author suggests the following groups of people purchase this report:

  • manufacturers of antidepressant
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Sertraline

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Sertraline in China

  • 2.1. Patent and Approval Status of Sertraline in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Sertraline in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Sertraline in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Sertraline in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Sertraline in Chinese Hospitals in 2014

  • 6.1. Aventis Pharma Group (Trade Name: Quyou)
  • 6.2. Shanghai New Asia Pharmaceutical Co., Ltd
  • 6.3. Tianjin Huajin Pharmaceutical Factory (Trade Name: Xitongjing)
  • 6.4. Zhejiang Jingxin Pharmaceutical Co., Ltd (Trade Name: Weitating)
  • 6.5. Zhejiang Huahai Pharmaceutical Co., Ltd (Trade Name: Leyuan)
  • 6.6. Pfizer, Inc. (US) (Trade Name: Zoloft)

7. Major Manufacturers of Sertraline in Chinese Market, 2010-2014

  • 7.1. Zhejiang Jingxin Pharmaceutical Co., Ltd
  • 7.2. Tianjin Huajin Pharmaceutical Factory
  • 7.3. Guangdong P.D. Pharmaceutical Co., Ltd
  • 7.4. Zhejiang Huahai Pharmaceutical Co., Ltd
  • 7.5. Pfizer, Inc.

8. Market Ooutlook of Sertraline in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Approval Information of Sertraline in China
  • Chart Sales Status of Sertraline in China
  • Chart Sales Value of Sertraline in China, 2010-2014
  • Chart Sales Value of Sertraline in Some Regions in China, 2010-2014
  • Chart Sales Volume of Sertraline in China, 2010-2014
  • Chart Sales Volume of Sertraline in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Sertraline for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Sertraline Made by Pfizer (US) in China, 2010-2014
  • Chart Sales Value and Market Share of Sertraline Made by Zhejiang Jingxin in China, 2010-2014
  • Chart Sales Value and Market Share of Sertraline Made by Guangdong P.D. in China, 2010-2014
  • Chart Sales Value and Market Share of Sertraline Made by Chengdu Leer in China, 2010-2014
  • Chart Sales Value and Market Share of Sertraline Made by Tianjin Huajin in China, 2010-2014
  • Chart Sales Value and Market Share of Sertraline Tablets in China, 2010-2014
  • Chart Sales Value and Market Share of Sertraline Capsules in China, 2010-2014
  • Chart Sales Volume and Market Share of Sertraline Tablets in China, 2010-2014
  • Chart Sales Volume and Market Share of Sertraline Capsules in China, 2010-2014
  • Chart Price of Sertraline Made by Aventis Pharma Group in Some Chinese Cities in 2014
  • Chart Price of Sertraline Made by Shanghai New Asia Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Sertraline Made by Tianjin Huajin Pharmaceutical Factory in Some Chinese Cities in 2014
  • Chart Price of Sertraline Made by Zhejiang Jingxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Sertraline Made by Zhejiang Huahai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Sertraline Made by Pfizer, Inc. (US) in Some Chinese Cities in 2014
Back to Top